Cytek Biosciences, Inc. CTKB Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenue, net by Geography | ||||||
| APAC | $39.94M-2.8% | $41.08M+4.3% | $39.4M+5.9% | $37.19M-2.9% | $38.31M+7.1% | |
| China | $18.8M-8.3% | $20.5M— | —— | —— | —— | |
| EMEA | $55.08M-1.4% | $55.88M+6.5% | $52.47M-8.5% | $57.32M-2.5% | $58.78M-5.7% | |
| Other | $8.05M-13.3% | $9.28M-14.3% | $10.82M+5.7% | $10.24M+0.6% | $10.17M+4.5% | |
| United States | $101.12M+6.2% | $95.26M+1.2% | $94.14M+3.1% | $91.29M+1.7% | $89.79M-3.1% | |
| Total by Geography | ||||||
| APAC | $38.26M+0.6% | $38.02M+0.8% | $37.72M+0.8% | $37.4M+1.4% | $36.89M+0.1% | |
| EMEA | $1.78M+0.8% | $1.76M-0.6% | $1.77M-5.4% | $1.88M+2.8% | $1.83M+0.4% | |
| United States | $34.84M+7.3% | $32.46M-0.8% | $32.71M-2.0% | $33.38M-1.0% | $33.7M-1.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Cytek Biosciences, Inc. break its business down?
- Cytek Biosciences, Inc. (CTKB) reports total revenue, net by geography across 5 parts — APAC, China, EMEA, Other and United States. Each is extracted from the segment footnotes and tracked over time.
- Where does Cytek Biosciences, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Cytek Biosciences, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
